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Objective: Negative symptoms largely account for poor outcome in psychotic disorders but remain
difficult to treat. A cognitive–behavioral approach to these symptoms showed promise in chronic
schizophrenia patients. We explored whether a combination of group and individual treatment focused
on social activation (CBTsa) could benefit patients recently diagnosed with a psychotic disorder.
Method: A single-blind randomized controlled trial enrolled 99 participants recently diagnosed with
schizophrenia or a related disorder that received treatment as usual (TAU; n  50), or TAU plus CBTsa
(n  49). Negative symptoms (Brief Negative Symptom Scale) and social withdrawal (Positive and
Negative Syndrome Scale) were primary outcomes. Secondary outcome measures included dysfunctional
beliefs (Dysfunctional Attitudes Scale-Defeatist Performance Attitude), stigma Internalized Stigma of
Mental Illness Scale (ISMIS), and symptom severity and functioning as measured with the Global
Assessment of Functioning (GAF). Outcomes were compared directly posttreatment and at follow-up (6
months posttreatment). Results: Intention-to-treat analyses showed significant improvement in GAF
symptoms (p  .02, d  0.36) and a decrease in negative symptoms on trend level (p  .08, d  0.29)
in CBTsa compared to TAU at posttreatment. These group differences were no longer apparent at 6
months follow-up. Social withdrawal and negative symptoms improved over time in both conditions.
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Conclusions: The current trial showed small positive effects on symptom severity posttreatment but did
not demonstrate maintenance of longer-term effects in favor of the CBTsa group. Findings suggest that
the treatment duration may have been too short to change dysfunctional beliefs, a potentially important
maintaining factor of negative symptom severity. Longer intervention periods in later, more stable stages
of the illness when intensive standard treatment has tapered off may yield more beneficial effects.
What is the public health significance of this article?
This study suggests that a cognitive–behavioral approach aimed at social activation might be
beneficial in accelerating the initial reduction of negative symptoms in patients recently diagnosed
with a psychotic disorder. However, to archive sustained treatment effects, and target defeatist
beliefs, additional treatment with a longer intervention period may be necessary.
Keywords: psychosis, CBT, social activation, negative symptoms
Supplemental materials: http://dx.doi.org/10.1037/ccp0000362.supp
Schizophrenia and related disorders belong to the most disabling
and costly disorders worldwide (Salize et al., 2009). Despite ex-
tensive treatment, a large proportion of individuals diagnosed with
schizophrenia or related psychotic disorders will not return to their
premorbid level of functioning (Horan et al., 2012). Negative
symptoms largely account for poor functional- and clinical out-
come (Fervaha, Foussias, Agid, & Remington, 2014; Kirkpatrick,
Fenton, Carpenter, & Marder, 2006; Lang, Kösters, Lang, Becker,
& Jäger, 2013; Milev, Ho, Arndt, & Andreasen, 2005) and have
long been considered to be highly treatment resistant (Kirkpatrick
et al., 2006). A recent meta-analysis showed statistically signifi-
cant beneficial effects of various psychological interventions di-
rected at negative symptoms; however, results were not considered
to be clinically significant (Fusar-Poli et al., 2015). These findings
are in line with a meta-analysis by our group, which showed only
a marginal effect of cognitive–behavioral therapy (CBT) on neg-
ative symptoms (Velthorst et al., 2015). Both studies recommend
further research on interventions for negative symptoms.
Based on the favorable effects that CBT exerts on positive
symptoms, Beck and colleagues developed and investigated the
efficacy of a new CBT approach focused on negative symptoms
(Grant, Huh, Perivoliotis, Stolar, & Beck, 2012). In their approach,
Beck and colleagues argued that negative symptoms are not solely
the consequence of neurocognitive impairments but are amplified
by feelings of stigmatization, dysfunctional beliefs and negative
expectations, which may negatively impact treatment. For exam-
ple, individuals who experience diminished concentration and
poorer functioning as a consequence of their psychosis may be-
come demoralized, in turn reinforcing feelings of incompetence,
inactivity, and avoidance behavior (Beck, 2008). Support for this
assumption stems from a recent meta-analysis that showed a
relationship between defeatist performance beliefs and functional
outcome (Campellone, Sanchez, & Kring, 2016). Negative expec-
tancies and dysfunctional beliefs are particularly well suited for a
cognitive–behavioral approach. In their trial Beck and colleagues
targeted a chronic schizophrenia population with severe negative
symptoms, with the primary aim of helping patients overcome
isolation and inactivity, thereby improving quality of life (Grant et
al., 2012). The authors found that participants treated with CBT
showed more improvement in global functioning and in avolition/
apathy (a subdomain of negative symptoms as measured with the
Scale for the Assessment of Negative Symptoms [SANS; Andrea-
sen, 1989]) compared to patients in the standard treatment condi-
tion. In an effort to increase feasibility and cost-effectiveness,
Staring et al. explored whether a shortened, 6-month version of the
protocol could also reduce negative symptoms. Their open pilot
study showed promising results (Staring, Ter Huurne, & van der
Gaag, 2013).
Despite favorable effects of these two studies, thus far the
intervention has only been tested in more chronic stages of schizo-
phrenia and related disorders, although social withdrawal is also
prominent in the early phase of the illness. Importantly, early
intervention is thought to be essential to improving illness course
and functional outcome (Harrison et al., 2001; Verma, Subrama-
niam, Abdin, Poon, & Chong, 2012). Therefore, in the present
randomized controlled trial study we aimed to examine whether a
CBT approach based on the manual of (Staring, Ter Huurne, & van
der Gaag, 2013) would also benefit individuals recently diagnosed
with schizophrenia or a related psychotic disorder.
In the treatment manual by Staring et al., the number of sessions
were reduced from 50 (Grant and colleagues) to 16–20 sessions
(Staring, Ter Huurne, & van der Gaag, 2013). For the purpose of
the present study, we slightly adapted this shortened manual to
meet specific needs of young individuals in the early stages of the
illness. For example, our treatment approach consisted of group-
and subsequent individual sessions to combine advantages of
group processes (such as practicing skills together and sharing
experiences) and peer interaction with individual CBT. During the
group sessions, buddy couples were formed to stimulate peer
support and generalization of skills to everyday life. Moreover, we
adapted the treatment manual to target social withdrawal specifi-
cally. Recent studies suggest that social withdrawal is not only a
strong predictor of conversion in those at ultrahigh risk for devel-
oping a first psychotic episode (Lyngberg et al., 2015; Velthorst et
al., 2009) but is also strongly associated with poorer prognosis and
poorer quality of life after illness onset (Mäkinen, Miettunen,
Isohanni, & Koponen, 2008).
In sum, we aimed to investigate whether CBT focused on social
activation (CBTsa) is more effective in reducing negative symp-
toms and social withdrawal in particular, compared to treatment as
usual (TAU) in individuals recently diagnosed with a psychotic






































































































152 POS ET AL.
functional beliefs and stigma, and whether CBTsa is associated




The current study was designed as a multisite randomized
controlled trial (RCT) in which CBTsa was compared to TAU in
alleviating social withdrawal in participants with a recent onset
psychotic disorder. Measurements were conducted at baseline (t0),
at first follow-up directly posttreatment (t1), and at second follow-
up, 6 months posttreatment (t2). The experimental CBTsa inter-
vention consisted of eight group sessions and six individual ses-
sions over the course of a maximum of 3 months. The study was
approved by the local ethics committee of the Academic Medical
Center (NL51493.018.14), and by the local ethics committees of
the other participating institutes.
Study Participants
Participants were recruited from four early psychosis treatment
centers in the Netherlands and one general mental health service in
the Netherlands: Arkin Psychiatric Institution in Amsterdam; Early
Psychosis Department of the Academic Medical Center (AMC) in
Amsterdam; Altrecht ABC Team in Utrecht; Centrum First Psy-
chosis Parnassia in The Hague; and InGeest outpatient psychiatric
service in Amsterdam.
To be eligible to participate in the study, participants had to be
between 18 and 36 years old and diagnosed with DSM–IV–TR
(American Psychiatric Association [APA], 2000) schizophrenia or
a related disorder with onset of their first psychotic episode 4
years prior to inclusion. Diagnosis was confirmed with the Struc-
tured Clinical Interview for DSM Disorders (First, Spitzer, Gib-
bon, & Williams, 2002). Patients with a comorbid diagnosis of
bipolar disorder or autism spectrum disorder were not included in
this study. Only participants with at least a mild level of social
withdrawal behavior, defined as a score of 3 on apathy/social
withdrawal as measured with the negative scale of the Positive and
Negative Syndrome Scale (PANSS; Kay, Opler, & Lindenmayer,
1988), or 2 on the social isolation items of the Brief Negative
Symptom Scale (BNSS; Kirkpatrick et al., 2011) were included.
The experience of positive symptoms was not an exclusion crite-
rion. However, individuals were not eligible when negative symp-
toms were primarily the result of hallucinations or delusions (e.g.,
withdrawal due to paranoid delusions). To determine whether
negative symptoms were primarily caused by positive symptoms,
during an initial screening session patients were explicitly asked
whether their reduced social engagement was related to the hearing
of voices or other psychotic experiences.
Procedure
After determining eligibility, participants who agreed to be
contacted by a researcher of the study were provided verbal and
written information about study procedures, and written informed
consent was obtained before baseline measurements were admin-
istered. Four psychologists with a master’s degree in clinical
psychology and four master students with a bachelor’s degree in
clinical psychology, who were blind to treatment allocation, car-
ried out assessments. Assessors received extensive training prior to
inclusion by certified trainers (Eva Velthorst and Frederike
Schirmbeck) for the PANSS, BNSS and GAF. The training con-
sisted of three training-videos for the PANSS, provided by the
AMC as part of their clinical training program and three trainings
videos for the BNSS provided by the original authors Dr. Kirk-
patrick and Dr. Strauss. For all videos gold standard scores and
scoring rationales were provided. Prior to assessment, all raters
participated in a consensus training and fulfilled the criteria of
interrater reliability 0.8. Ongoing weekly supervision was pro-
vided to ensure consensus across raters.
If blinding was broken, another researcher still blind to the
condition carried out the assessment. Subjects were randomly
assigned per site by a researcher not involved in the research team
to either the CBTsa condition or TAU by block-randomization
(www.randomizer.org), sequencing participant assignments by
block to insure an equal number of individuals in each intervention
arm.
Sample Size Calculation
Sample size calculation was based on the study of Grant et al.
(2012), which found a larger mean reduction in avolition-apathy of
the CBT condition compared to standard treatment of d  0.66
(Grant et al., 2012). Based on this result, and upon the commonly
held assumption that recent onset subjects are more likely to
change than the more chronic population, we estimated to find an
effect size of (at least) .66 in our study. With an alpha of 0.5;
power  80%; effect-size .66 and taking into account an expected
dropout rate of 20%, analyses resulted in 72  20%  87 partic-
ipants  44 per group. Because of our multicenter design we also
accounted for a variance inflation factor, therefore we calculated
the intraclass correlation coefficient (ICC) of the PANSS negative
symptom scores of a study targeting a similar population and
setting (Genetic Risk and Outcome of Psychosis study), in which
four centers participated. The ICC in this study was .146. Follow-
ing the literature, we then used the following formula:
1  (m1)  ICC (m  number of participating centers). For
our study, this meant that we had to increase the sample size (87)
by a factor of: 1  (31)  .146  1.292, resulting in a total
estimated sample size of: 1.292  87  112 individuals (56 per
condition).
Primary Outcome
The BNSS, a scale primarily designed to assess (change in)
negative symptoms in clinical trials (Kirkpatrick et al., 2011), was
used to assess the primary outcome negative symptoms. The Dutch
translation was conducted by coauthors in agreement with original
authors (Staring, Velthorst, et al., 2013). The BNSS constitutes 13
items that can be rated in a 30-min interview, assessing clinically
meaningful negative symptoms in five subdomains: blunted affect,
alogia, a-sociality, anhedonia, avolition, and a separate item that
measures lack of distress/dysphoria. Sample items of the sub-
domain “a-sociality” (of main interest in the present study) in-
clude, “When you spent time with . . ., did you contact them or did






































































































153CBT SOCIAL ACTIVATION IN RECENT ONSET PSYCHOSIS
personal things?”, or “Some people like to be by themselves;
others like to be around other people. What do you prefer?”
Reliability analyses indicate that the BNSS has excellent inter-
nal consistency and temporal stability (Kirkpatrick et al., 2011). In
the current study, Cronbach’s alpha of the BNSS total score was
0.81.
Group differences in negative symptom severity, particularly
social withdrawal were additionally explored by means of the
PANSS (Kay et al., 1988). The PANSS has been translated into
Dutch by Linszen, de Haan, Kuipers and Dingemans, AMC De-
partment of Psychiatry (1995). Two subdomains of negative symp-
toms have been confirmed in two large Dutch cohorts (Liemburg
et al., 2013). For our study purpose, PANSS negative symptom
scores were measured with the subdomain ‘social emotional with-
drawal,’ which comprises active and passive social withdrawal
and- avoidance behavior.
Secondary Outcomes
Global Assessment of Functioning (GAF) was administered
using the two functioning (GAF-F) and symptoms (GAF-S) sub-
scales (Jones, Thornicroft, Coffey, & Dunn, 1995). The Dutch
version of the GAF is part of the DSM–IV–TR (APA, 2000) and
has been validated in Dutch patients (Havenaar et al., 2004). The
two subscales are rated on a scale from 1 to 100 and measure the
current level of symptoms and functioning in the last month. For
the GAF subscales, a score between 1 and 10 signifies “a persistent
danger of severely hurting self or others (e.g., recurrent violence)/
persistent inability to maintain minimal personal hygiene,”
whereas a score between 91 to 100 indicates “no symptoms/
superior functioning in a wide range of activities.” It is a widely
used and valid measurement of functioning.
Dysfunctional beliefs were measured with the Dutch version of
the Dysfunctional Attitudes Scale-Defeatist Performance Attitude
(DAS-DPA). The scale is a 15 item measure (Beck, Grant, Huh,
Perivoliotis, & Chang, 2013) assessing the beliefs of one’s ability
to perform tasks and the likelihood of success, derived from the
40-item Dysfunctional Attitude Scale (DAS; Weissman & Beck,
1978). Translation was conducted by A. B. P. Staring, in agree-
ment with the original authors (i.e., Beck and Grant; Staring, Ter
Huurne, & van der Gaag, 2013). Items are rated on a 7-point Likert
scale, ranging from 1 (agree totally) to 7 (disagree totally), with
lower scores representing higher dysfunctional beliefs. Questions
include, “It is difficult to be happy unless one is good looking,
intelligent, rich and creative”, and “People will probably think less
of me if I make a mistake.” Cronbach’s alpha in the current study
was 0.90.
Feelings of stigma were measured with the Internalized Stigma
of Mental Illness Scale (ISMI; Boyd Ritsher et al., 2003), trans-
lated and validated in Dutch by Brohan et al. (2011). The 29-item
questionnaire is rated on a 4-point Likert-type scale, ranging from
1 (strongly agree) to 4 (strongly disagree). It contains five sub-
scales: alienation, stereotype endorsement, perceived discrimina-
tion, social withdrawal, and stigma resistance. For this study, a
sum-score of the scales alienation, stereotype endorsement, per-
ceived discrimination and social withdrawal was used (Cronbach’s
alpha  .91). A sample question of alienation includes, “People
without mental illness could not possibly understand me,” and of
perceived discrimination: “Nobody would be interested in getting
close to me because I have a mental illness”.
Treatment Conditions
CBTsa. Participants randomized to the CBTsa condition re-
ceived eight group sessions of 1 hour/twice a week followed by six
weekly individual sessions of 45 min. Treatment was delivered at
each of the four recruitment sites over a period of 3 months. The
overall aim of the treatment was to modify dysfunctional beliefs
and to increase engagement in constructive social activity in indi-
viduals with prominent negative symptoms. The primary focus
was to help participants become more active in reaching personal
social goals.
Group sessions. During the first session of the group therapy,
psychoeducation with a focus on negative symptoms (e.g., anhe-
donia, lack of energy, cognitive deficits, problem in social inter-
action and social withdrawal) was provided. Patients were asked to
share their experiences and to define their individual social goals
(e.g., [re] connect with friends, [re] engage in team sport) aimed to
increase social interaction. To promote peer support as one of the
major components of the group-based intervention part, buddy
couples were formed. These couples worked together during ses-
sions and were encouraged to support each other between sessions
in completing their homework (e.g., by sending reminders). At the
start of the second session, goals with the highest personal value
were selected and divided into smaller steps necessary to reach
these goals. Participants were asked to rate which obstacles in
reaching their goals they anticipated. Emphasis was placed on
dysfunctional beliefs regarding one’s own cognitive functioning,
skills, or the expected (lack of) pleasure or social devaluation (e.g.,
“I cannot enjoy things anymore,” “I am unable to concentrate and
memorize anything and will not be able do have an interesting
conversation”). Psychoeducation during this session was specifi-
cally focused on the cognitive model of negative symptoms, em-
phasizing the role of dysfunctional beliefs, avoidance behavior,
and demoralization. Subsequent sessions focused on challenging
anticipated and experienced obstacles using standardized material
such as cognitive restructuring worksheets, role-plays, and on-site
behavioral experiments. Specific actions to reach one’s personal
goal were planned in detail during the sessions, and the participant
was asked to carry out that step before the next planned session as
homework assignment. At the start of each following session,
homework assignments were discussed. To maximize a sense of
personal efficacy, each failure of the patient to execute a new
behavior was interpreted as the therapist’s fault (e.g., due to
insufficient preparation or setting goals too high). The underlying
idea is that small successes are prerequisite to the experience of
hope and personal efficacy. To facilitate engagement and gener-
alization of learned skills to daily functioning, participants were
encouraged to actively participate in discussions, role-plays and
behavior experiments.
Individual sessions. Individual therapy sessions were aimed
at the continuation of social activation and achievement of per-
sonal goals through a personalized focus on the person’s main
dysfunctional beliefs and associated behaviors, and countering
obstacles to these goals. Rather than providing a session-by-
session protocol, the treatment manual provided material for psy-
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Intervention tools were based on different elements of demoral-
ization (e.g., cognitive techniques used to investigate dysfunctional
beliefs and behavior, such as Socratic dialogue, behavioral and
cognitive experiments; dimensional evaluation of negative or ste-
reotype self-image etc.; cognitive imagery techniques (imagining
the steps needed to achieve new goals); and behavioral techniques
(activity scheduling, exposure to new situations that trigger anxiety
etc.). The choice for a particular combination of the above-
mentioned techniques was based on the individual needs and goals.
Treatment Fidelity and Adherence
To ensure treatment fidelity and adherence to treatment, thera-
pists received extensive training by A. B. P. Staring (adaptor of the
original manual of Grant at al. (Staring et al., 2010) and were
supervised by C. J. Meijer and F. Schirmbeck throughout the
study. Feasibility of the treatment and treatment manual proved to
be good in the pilot study of Staring et al. (Staring, Ter Huurne, &
van der Gaag, 2013). MSc level psychologists provided the group
and individual CBT sessions. To ensure treatment implementation,
adherence to the manual and coherence across sites, sessions were
routinely monitored by videotapes (group sessions) and audiotapes
(individual sessions). In addition, on-site and telephone supervises
were provided. Treatment receipt and enactment was promoted by
active participation during sessions, on-site exercises including
cognitive and behavioral experiments and homework assignments,
which were discussed at the beginning of the following session to
ensure understanding and application of learned skills.
TAU
Every participant in the TAU condition received either inpatient
treatment, day-treatment or outpatient treatment at one of the
collaborating (local community) mental health centers. Across
sites, TAU consisted of early intervention programs where pa-
tient’s symptoms, functioning and medication use are monitored
for 3 years. At minimum, treatment as usual consisted of antipsy-
chotic medication and supportive therapy. In addition, TAU could
involve psycho-education, family support, physical health care,
psychomotor therapy and vocational therapy. The latter includes
individual placement and support (IPS), intended to support pa-
tients in their efforts to achieve employment and reintegration.
Participants in the TAU condition were not allowed to receive any
form of CBT or any intervention that was specifically focused on
social activation. The teams of the participating psychiatric ser-
vices included psychiatrists, psychologists, psychiatric nurses and
social workers.
Data Analyses
For data analyses, SPSS 22 was used. All treatment effects were
analyzed on an intention to treat basis using a (generalized) linear
mixed model, the recommended approach to longitudinal designs
as estimates are based on all available data. To determine treatment
effects the primary (BNSS, PANSS) and secondary (ISMI, DAS-
DPA, GAF) outcome measures were entered as dependent vari-
ables, assessment time, treatment condition and Treatment  Time
interactions were included as fixed effects in the model. Assess-
ment time was included as a categorical variable. The intercept
was treated as random effect. Mixed effects models use full infor-
mation maximum-likelihood estimation to adjust the likelihood
function so that each case contributes information on the variables
that are observed.
Analyses were conducted over time (i.e., overall assessment
points) and were repeated for baseline posttreatment effects and
baseline follow-up effects. Because of between-groups differences
at baseline and significant associations with most outcome vari-
ables, all analyses were controlled for gender, relationship status,
and recruitment site by including these variables as covariates to
the model.
For exploratory purposes all analyses were repeated using a (a)
“per protocol” approach, including only those individuals that
completed at least 65% of the therapy sessions, as well as a (b)
“completer” approach, including only those individuals with out-
come data available at all time points. We used a two-tailed
significance level of p  .05. Cohen’s d effect sizes were com-
puted for significant effects.
Results
Sample Characteristics
Figure 1 presents the participant flowchart of the study. Of the
305 individuals screened for eligibility, 99 were randomized to one
of the two conditions.
Of the complete study sample, 20.3% presented with active
delusions and 32.3% with active hallucinations with mild to mod-
erate severity. Average positive symptom severity of our sample
was relatively low (M  11.3, SD  3.4). Mean negative symptom
severity at baseline was considerably higher (M  17.8, SD  5.5)
with 76.8% reporting moderate to severe social withdrawal and
37.4% with moderate to severe emotional withdrawal. Overall
baseline average depression scores on the Calgary Depression
Scale were relatively low (M  2.8, SD  2.9), with 15.5% of our
sample scoring 6, indicating clinically relevant depressive symp-
toms (Addington, Shah, Liu, & Addington, 2014). Fifty-one per-
cent of the participants presented with serious symptoms of schizo-
phrenia (GAF-S  50) and 80.2% with serious impaired
functioning (GAF-F  50). See Table 1 for demographical and
clinical information. Baseline scores on relevant outcome mea-
sures by condition are described in Table 1.
Loss to Follow-Up
Dropout rates did not differ between the CBTsa (20.4%) and
TAU (30%) condition at follow-up (2  1.206, p  .272).
Individuals who dropped out of the study did not significantly
differ from those who completed the study in age, ethnicity or
years of education. However, dropouts included a higher percent-
age of women (2  6.093, p  .014). No significant differences
were found in terms of severity of positive, negative or depressive
symptoms, or functioning. Group-wise comparisons of dropouts
and individuals who completed the study also did not show any
significant differences, apart from a higher dropout-rate of women
in the CBTsa condition (2  4.421, p  .035).
Adherence to the Intervention
Of those randomized to the CBTsa condition, 7 individuals






































































































155CBT SOCIAL ACTIVATION IN RECENT ONSET PSYCHOSIS
treatment. Another 11 of the remaining 42 (26.2%) were defined as
noncompleters, adhering to less than 65% of the trainings sessions.
Of these, five were lost during the first half of the group training,
another five were lost at the end of the group training and did not
start with individual therapy and one attended only 50% of group
and individual sessions. The average number of followed CBTsa-
group sessions among patients who started treatment was 6.7
(SD  1.9); range  1–8, and of individual sessions 4.0 (SD 
2.5); range  0–6.
Intent-to-Treat Analyses
ITT results are shown in Table 2. Significant time effects
revealed an overall decrease in most outcome variables in both
conditions over the total assessment period. No overall Group
(2)  Time (3) interaction effects were apparent. Baseline-
posttreatment analyses showed that compared to TAU, the CBTsa
group showed a slightly steeper decrease in negative symptoms as
measured with the BNSS between t0 and t1: z  1.74, p  .082,
d  0.29. However, this difference leveled out at follow-up.
Also, a significant Group (2)  Time (2) interaction effect was
found for GAF symptoms: z  2.33, p  .024, d  0.36 at post
treatment. Compared with TAU, patients randomized to the inter-
vention group showed a faster decrease in overall symptom sever-
ity at posttreatment. This difference was no longer apparent at
follow-up. No other significant Group (2)  Time (2) interaction
effects were found at posttreatment or follow-up. Figure 2a and 2b
display the overall course of BNSS and GAF-S symptom scores.
Per Protocol and Completer Analyses
For exploratory purposes, analyses were repeated using a “per
protocol” and “completer” approach. As can be seen in Supple-
mentary Tables S1 and S2 in the online supplemental material,
findings were similar to those resulting from the ITT analyses.
Discussion
In the present study, we aimed to investigate the effectiveness of
a CBTsa intervention on negative symptoms, dysfunctional be-
liefs, and general functioning in individuals with a recent onset
psychosis. There was a slight trend showing a steeper decrease in






































































































156 POS ET AL.
negative symptoms and significantly larger decrease in overall
symptom severity in the intervention group compared to the TAU
group posttreatment. However, these effects were small and
between-groups differences at post treatment were not maintained
at 6 months follow-up. These findings correspond to the small
effects found in the meta-analysis of Fusar-Poli et al. (2015) and
Velthorst et al. (2015). We found no significant differences in the
reduction of measures of social withdrawal or dysfunctional be-
liefs between conditions. Overall, our study could not support
earlier favorable findings of social activation CBT compared to
TAU on negative symptoms as observed in chronic patients with
schizophrenia in the study of Grant et al. (2012).
Contrary to the lack of improvement in avolition/apathy in TAU
observed in Grant et al. (2012), our results showed significant time
effects in both conditions with improvement on most measures of
negative symptoms. These inconsistent findings could be due to
differences in sample characteristics. In a study by Chang et al.
(2011) patients with a first-episode schizophrenia spectrum disor-
ders showed substantial reduction of primary negative symptoms
in the initial year of treatment after first admission. The authors
concluded that contrary to the persistence of negative symptoms in
the later stages of the illness, severity of negative symptoms
fluctuates considerably in the first year after psychotic manifesta-
tion.
Significant improvement in negative symptom severity in both
study conditions may also suggest that standard treatment offered
by early intervention psychosis teams in the Netherlands already
has an effect on the severity of negative symptoms. One of the
characteristics of standard treatment in early psychosis programs
concerns the focus on reintegration, such as IPS. Although not
specifically targeting psychopathology, a randomized controlled
trial showed significant effect of IPS on negative symptoms (Hoff-
mann, Jäckel, Glauser, & Kupper, 2012). Hence, this behavioral
approach might provide patients with the means they need to
participate in work and education and in turn gives them oppor-
tunities to engage in social contact and experience rewarding and
meaningful social interactions.
Despite the lack of sustained differential treatment effects, we
did find some positive effects of CBTsa directly posttreatment
regarding overall symptom severity, and more specifically in the
Table 1
Demographical and Clinical Information of the Experimental
and Control Condition at Baseline
Demographic information
CBTsa (n  49) TAU (n  50)
M (SD) M (SD)
Age 25.14 (4.47) 25.72 (4.44)
Sex ratio male/female 37/12 43/7
Ethnicity % minority 69.4 51.0
Diagnosis according to DSM IV-TR
Schizophrenia disorder 29 34
Schizoaffective disorder 7 3
Psychotic disorder NOS 10 9
Other psychotic diagnosis 4 4
Current cannabis use % 25.5 17.0
Antipsychotic medication % 85.4 98.0
Note. CBTsa  cognitive–behavioral approach aimed at social activa-










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































157CBT SOCIAL ACTIVATION IN RECENT ONSET PSYCHOSIS
decrease of negative symptoms. These results may indicate that
CBTsa shortly after first admission may be beneficial in acceler-
ating the reduction of symptoms.
However, as mentioned previously, the beneficial effect of
CBTsa was no longer apparent at follow-up. Furthermore, 6
months after the end of treatment participants in both the inter-
vention and TAU group reported remaining clinically relevant
negative symptoms.
One important factor that may help explain the lack of a favor-
able effect in longer term improvements of negative symptoms in
the CBTsa condition was our inability to establish a positive
change in the proposed working mechanism; minimizing dysfunc-
tional beliefs and/or (self) stigma. Based on the cognitive model of
negative symptoms, we assumed that defeatist beliefs play a cen-
tral role in the development and maintenance of negative symp-
toms, specifically social withdrawal. Accordingly, in their pilot
study, Staring et al. found that a reduction in dysfunctional beliefs
partially mediated the observed change in negative symptoms after
CBT treatment (Staring, Ter Huurne, & van der Gaag, 2013). This
finding was recently supported by Granholm and colleagues (Gra-
nholm, Holden, & Worley, 2018).
It may be that our shorter treatment protocol was not intensive
enough to ensure a sustained differential effect and improvements
in the proposed working mechanism defeatist beliefs. The studies
that showed successful improvement all had a significantly longer
treatment duration (Granholm et al., 2018; Morrison et al., 2014;
Staring, Ter Huurne, & van der Gaag, 2013). Furthermore, a
substantial number of participants in the CBTsa condition were
lost during or at the end of group therapy before individual
sessions started and could therefore not benefit from individual
work on dysfunctional beliefs and activation plans. Lincoln et al.
(2017) recently emphasized that individualized treatment planning
is needed to increase the effectiveness of approaches aiming to
reduce negative symptoms. Based on these findings, it may be
advisable for future studies to start with more individual sessions,
personal attention, and practice. Subsequently, in a second step—
when more familiar with the content of CBTsa and a personal case
formulation—participants may be more prone to benefit from
‘peer support’ groups. Furthermore, because psychotic disorders
often have an episodic course, and studies indicate that psycho-
therapy treatment gains decline over time, some patients may need
access to booster sessions and additional psychotherapy to manage
symptoms and sustain treatment gains or further improve them
over time. Fowler et al. (2018) recently reported promising results
of an RCT investigating the effect of social recovery therapy at
four early intervention services in the United Kingdom. In contrast
to our study, their approach not only had a longer treatment
duration (9 months), but also focused extensively on the inclusion
of family members, employers, and education providers. This
integrative approach with a stronger focus on the close environ-
ment of the patient may be needed to establish an enduring positive
treatment effect. Future research targeting defeatist beliefs and
negative symptoms should address these limitations.
Finally, sustained additive effects of CBT targeting negative
symptoms may be more likely in more chronic patient groups that
show enduring negative symptoms and dysfunctional beliefs.
Our study should be considered in the context of some limita-
tions. First, we did not meet our recruitment target (n  112) and
a considerable number of participants were lost to follow-up.
Because of the substantial number of pretreatment loss and non-
completers in the intervention condition, we chose a liberal crite-
rion of at least 65% of attended sessions to define completers.
Regardless, dropout rates may have contributed to insufficient
power in the per protocol analyses. However, dropout rates were
comparable to those in the meta-analyses of Fernandez, Salem,
Swift, and Ramtahal (2015), who reported average weighted drop-
out rates from CBT of 15.9% pretreatment and 26.2% during
treatment. Second, more women were lost to follow-up in the CBT
condition, which might have influenced outcome of the completer
analyses. However, no differences were found between the ITT
and completer analyses.
Third, current cannabis abuse was not included as a covariate





















Figure 2. Estimated marginal means of Brief Negative Symptom Scale
and Global Assessment of Functioning Symptom subscale as a function of
treatment group in the intent-to-treat sample. CBT  cognitive–behavioral






































































































158 POS ET AL.
investigate the effect of CBTsa in better-powered studies—poten-
tially with different, more sensitive measures.
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